Biologics and Biosimilars Regulations and Registration in Australia (TGA)
The Australian healthcare system has transformed with the availability of biologic and biosimilar medications. The market for Australian biosimilars, which […]
Biologics
Biologics and Biosimilars Regulations and Registration in Brazil
According to the Drugs Sector Regulation Chamber (CMED) in 2022, the Brazilian pharmaceutical sector generated US $17.2 billion in sales